Innovative perspectives of immunotherapy in head and neck cancer. From relevant scientific rationale to effective clinical practice

被引:8
作者
Lalami, Y. [1 ]
Awada, A. [1 ]
机构
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, Blvd Waterloo, B-1211000 Brussels, Belgium
关键词
Immune system; Head and neck cancer; Tumor immune infiltration; Immunotherapy; HPV; SQUAMOUS-CELL CARCINOMA; REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; ANTIGEN-PROCESSING MACHINERY; HPV-ASSOCIATED HEAD; LONG-TERM SURVIVAL; HUMAN-PAPILLOMAVIRUS; PHASE-III; OROPHARYNGEAL CANCER; ANTITUMOR IMMUNITY;
D O I
10.1016/j.ctrv.2016.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is now well established that head and neck cancer carcinogenesis is characterized by genetic instability and several immune defects, leading to unique host-tumor interactions. In such condition, recent improved comprehension and relevant findings could lead to identification of innovative molecular therapeutic targets, achieving considerable clinical and translational research. This review aims to summarize and to highlight most recent and relevant scientific rationale in this era of immunotherapy revival, and to correlate it to the near future clinical practice for the management of this challenging disease. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:113 / 123
页数:11
相关论文
共 193 条
[1]  
Adelstein David J, 2009, Head Neck, V31, P1393, DOI 10.1002/hed.21269
[2]   Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck [J].
Albers, A ;
Abe, K ;
Hunt, J ;
Wang, J ;
Lopez-Albaitero, A ;
Schaefer, C ;
Gooding, W ;
Whiteside, TL ;
Ferrone, S ;
DeLeo, A ;
Ferris, RL .
CANCER RESEARCH, 2005, 65 (23) :11146-11155
[3]   The clinical implications of antitumor immunity in head and neck cancer [J].
Allen, Clint T. ;
Judd, Nancy P. ;
Bui, Jack D. ;
Uppaluri, Ravindra .
LARYNGOSCOPE, 2012, 122 (01) :144-157
[4]   Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells [J].
Alvaro, T ;
Lejeune, M ;
Salvadó, MT ;
Bosch, R ;
García, JF ;
Jaén, J ;
Banham, AH ;
Roncador, G ;
Montalbán, C ;
Piris, MA .
CLINICAL CANCER RESEARCH, 2005, 11 (04) :1467-1473
[5]   Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].
Ang, K. Kian ;
Harris, Jonathan ;
Wheeler, Richard ;
Weber, Randal ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Westra, William H. ;
Chung, Christine H. ;
Jordan, Richard C. ;
Lu, Charles ;
Kim, Harold ;
Axelrod, Rita ;
Silverman, C. Craig ;
Redmond, Kevin P. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35
[6]  
[Anonymous], J THORAC ONCOL S2
[7]  
Antonia SJ, 2013, J THORAC ONCOL S2, V8
[8]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[9]   Head and neck cancer [J].
Argiris, Athanassios ;
Karamouzis, Michalis V. ;
Raben, David ;
Ferris, Robert L. .
LANCET, 2008, 371 (9625) :1695-1709
[10]   Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial [J].
Argiris, Athanassios ;
Ghebremichael, Musie ;
Gilbert, Jill ;
Lee, Ju-Whei ;
Sachidanandam, Kamakshi ;
Kolesar, Jill M. ;
Burtness, Barbara ;
Forastiere, Arlene A. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) :1405-1414